MYC and breast cancer: Thus, the establishment of the MCF7 cell line with 88.41% stable expression of the exogenous MYC sequence is a strong indicator of the effectiveness and stability of the transfection process, offering a robust and reliable platform for investigating the molecular mechanisms and cellular interactions associated with the MYC gene in the context of breast cancer.